Conditioning mechanisms and psychoneuroimmunology;Lernpsychologische aspekte in der psychoneuroimmunologie (PNI)

PPmP Psychotherapie Psychosomatik Medizinische Psychologie

Volumn 55, Issue 1, 2005, Pages 5-19

  Stockhorst, Ursula ^a   Klosterhalfen, Sibylle ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Classical conditioning; CNS; Immunomodulation; Instrumental conditioning

Indexed keywords

ADJUVANT ARTHRITIS; AUTOIMMUNITY; CONDITIONED REFLEX; CONDITIONING; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; INSTRUMENTAL CONDITIONING; LUPUS ERYTHEMATOSUS; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; NEUROPSYCHOLOGY; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; PSYCHOSOMATICS; REVIEW; SYSTEMATIC REVIEW; TUMOR IMMUNOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; CONDITIONING (PSYCHOLOGY); CONDITIONING, CLASSICAL; CONDITIONING, OPERANT; HUMANS; IMMUNITY; IMMUNOLOGIC FACTORS; PSYCHONEUROIMMUNOLOGY;

EID: 13144251161     PISSN: 09372032     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-834552     Document Type: Review

References (94)

1. Klosterhalfen S, Klosterhalfen W. The conditioning of immunopharmacological effects: Critical remarks and perspectives. In: Husband AJ (ed): Psychoimmunology, CNS-immune interactions. Boca Raton: CRC Press, 1993: 149-162
2. Ramsay DS, Woods SC. Biological consequences of drug administration: Implications for acute and chronic tolerance. Psychol Rev 1997; 104: 170-193
3. Ader R, Cohen N. The influence of conditioning on immune responses. In: Ader R, Felten DL, Cohen N (eds): Psychoneuroimmunology. San Diego: Academic Press, 1991: 611-646
4. Solvason HB, Ghanta VK, Hiramoto RN. The identity of the unconditioned stimulus to the central nervous system is interferon-β. J Neuroimmunol 1993; 45: 75-82
5. Turnbull AV, Rivier C. Regulation of the HPA axis by cytokines. Brain Behav Immun 1995; 9: 253-275
6. Maier SF, Watkins LR. Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998; 105: 83-107
7. Metal'nikov S, Chorine V. Rôle des reflexes conditionnels dans l'immunitée. Ann Inst Pasteur (Paris) 1926; 40: 893-900
8. Spector NH. Konditionierung von Immunreaktionen. In: Kaschka WP, Aschauer HN (Hrsg): Psychoimmunologie. Stuttgart: Thieme, 1990: 43-50
9. Ader R, Cohen N. Behaviorally conditioned immunosuppression. Psychosom Med 1975; 37: 333-340
10. Overmier JB, Seligman MEP. Effects of inescapable shock upon subsequent escape and avoidance responding. J Comp Physiol Psychol 1967; 63: 28-33
11. Janeway CA, Travers P, Walport M, Shlomchick M. Immunologie. Heidelberg: Spektrum Akademischer Verlag, 2002
12. Schulz K-H, Schedlowski M, Schulz H, Kugler J. Struktur und Funktion des Immunsystems - Eine kurze Einführung. Z Med Psychol 1997; 2: 53-58
13. Segerstrom SC, Miller GE. Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psych Bull 2004; 130: 601-630
14. Herberman RB, Ortaldo JR. Natural killer cells: Their role in defenses against disease. Science 1981; 214: 24-30
15. Ader R, Cohen N. Psychoneuroimmunology: Conditioning and stress. Annu Rev Psychol 1993; 44: 53-85
16. Ader R. Letter to the editor. Psychosom Med 1974; 36: 183-184
17. Garcia J, Kimeldorf DJ, Koelling RA. Conditioned aversion to saccharin resulting from exposure to gamma radiation. Science 1955; 122: 157-158
18. Klosterhalfen S, Klosterhalfen W. Conditioned taste aversion and traditional learning. Psychol Res 1985; 47: 71-94
19. Klosterhalfen S, Klosterhalfen W. Classically conditioned effects of cyclophosphamide on white blood cell counts in rats. Ann N Y Acad Sci 1987; 496: 569-577
20. Roudebush RE, Bryant HU. Conditioned immunosuppression of a murine delayed type hypersensitivity response: Dissociation from corticosterone elevation. Brain Behav Immun 1991; 5: 308-317
21. Exton MS, Hörsten S von, Schult M et al. Behaviorally conditioned immunosuppression using cyclosporine A: Central nervous system reduces IL-2 production via splenic innervation. J Neuroimmunol 1998; 88: 182-191
22. Stockhorst U, Spennes-Saleh S, Körholz D et al. Anticipatory symptoms and anticipatory immune responses in pediatric cancer patients receiving chemotherapy: Features of a classically conditioned response? Brain Behav Immun 2000; 14: 198-218
23. Longo DL, Duffey PL, Kopp WC et al. Conditioned immune response to interferon-γ in humans. Clin Immunol 1999; 90: 173-181
24. Rogers MP, Reich P, Strom TB, Carpenter CB. Behaviorally conditioned immunosuppression: Replication of a recent study. Psychosom Med 1976; 38: 447-451
25. Napolitano F, Rosa G de, Grasso F et al. Conditioned inhibition of antibody response and CD4 positive cells. Physiol Behav 1998; 64: 395-398
26. Morato EF, Gerbase-DeLima M, Gorczynski RM. Conditioned immunosuppression in orally immunized mice. Brain Behav Immun 1996; 10: 44-54
27. Djuric VJ, Bienenstock J. Learned sensitivity. Ann Allergy 1993; 71: 5-15
28. Russell M, Dark KA, Cummins RW et al. Learned histamine release. Science 1984; 225: 733-734
29. MacQueen G, Marshall J, Perdue M et al. Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science 1989; 243: 83-85
30. Ader R, Kelly K, Moynihan JA et al. Conditioned enhancement of antibody production using antigen as the unconditioned stimulus. Brain Behav Immun 1993; 7: 334-343
31. Alvarez-Borda B, Ramírez-Amaya V, Pérez-Montfort R, Bermúdez-Rattoni F. Enhancement of antibody production by a learning paradigm. Neurobiol Learn Mem 1995; 64: 103-105
32. MacKenzie JN. The production of the so-called "rose cold" by means of an artificial rose. Am J Med Sci 1886; 91: 45-57
33. Dekker E, Groen J. Reproducible psychogenic attacks of asthma. J Psychosom Res 1956; 1: 58-67
34. Dekker E, Pelser HE, Groen J. Conditioning as a cause of asthmatic attacks. J Psychosom Res 1957; 2: 97-108
35. Gauci M, Husband AJ, Saxarra H, King MG. Pavlovian conditioning of allergic rhinitis in humans. In: Husband AJ (ed): Psychoimmunology, CNS-immune interactions. Boca Raton: CRC Press, 1993: 121-125
36. Booth RJ, Petrie KJ, Brook RJ. Conditioning allergic skin responses in humans: A controlled trial. Psychosom Med 1995; 57: 492-495
37. Cohen N, Ader R, Green N, Bovbjerg D. Conditioned suppression of a thymus-independent antibody response. Psychosom Med 1979; 41: 487-491
38. O'Reilly CA, Exon JH. Cyclophosphamide-conditioned suppression of the natural killer cell response in rats. Physiol Behav 1986; 37: 759-764
39. Janz LJ, Green-Johnson J, Murray L et al. Pavlovian conditioning of LPS-induced responses: Effects on corticosterone, splenic NE and IL-2 production. Physiol Behav 1996; 59: 1103-1109
40. Dyck DG, Janz L, Osachuk TAG et al. The Pavlovian conditioning of IL-1 induced glucocorticoid secretion. Brain Behav Immun 1990; 4: 93-104
41. Bovbjerg D. Interleukin 1 induces taste aversion as well as decreased food and water consumption in mice. Psychosom Med 1988; 50: 196
42. Goebel U, Trebst A, Steiner J et al. Behavioral conditioning of immunosuppression is possible in humans. FASEB J 2002; 16: 1869-1873
43. Bovbjerg D, Cohen N, Ader R. Behaviorally conditioned enhancement of delayed-type hypersensitivity in the mouse. Brain Behav Immun 1987; 1: 64-71
44. Smith GR, McDaniel SM. Psychologically mediated effect on the delayed hypersensitivity reaction to tuberculin in humans. Psychosom Med 1983; 45: 65-70
45. Coussons ME, Dykstra LA, Lysle DT. Pavlovian conditioning of morphine-induced alterations of immune status. J Neuroimmunol 1992; 39: 219-230
46. Buske-Kirschbaum A, Kirschbaum C, Stierle H et al. Conditioned manipulation of natural killer (NK) cells in humans using a discriminative learning protocol. Biol Psychol 1994; 38: 143-155
47. Buske-Kirschbaum A, Kirschbaum C, Stierle H et al. Conditioned increase of natural killer cell activity (NKCA) in humans. Psychosom Med 1992; 54: 123-132
48. Exton MS, Auer AK von, Buske-Kirschbaum A et al. Pavlovian conditioning of immune function: Animal investigation and the challenge of human application. Behav Brain Res 2000; 110: 129-141
49. Kirschbaum C, Jabaaij L, Buske-Kirschbaum A et al. Conditioning of drug-induced immunomodulation in human volunteers: A European collaborative study. Br J Clin Psychol 1992; 31: 459-472
50. Hsueh C-M, Chen S-F, Chanta VK, Hiramoto RN. Expression of the conditioned NK cell activity is β-endorphin dependent. Brain Res 1995; 678: 76-82
51. Hsueh C-M, Kuo J-S, Chen S-F et al. Involvement of catecholamines in recall of the conditioned NK cell response. J Neuroimmunol 1999; 94: 172-181
52. Schedlowski M, Falk A, Rohne A et al. Catecholamines induce alterations of distribution and activity of human natural killer (NK) cells. J Clin Immunol 1993; 13: 344-351
53. Exton MS, Hörsten S von, Strubel T et al. Conditioned alternations of specific blood leukocyte subsets are reconditionable. Neuroimmunomodulation 2000; 7: 106-114
54. Stockhorst U, Klosterhalfen S. Klinische Anwendungen der klassischen Konditionierung von Immunfunktionen. In: Schulz K-H, Kugler J, Schedlowski M (Hrsg): Psychoneuroimmunologie. Bern: Huber, 1997: 373-388
55. Ader R, Cohen N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science 1982; 215: 1534-1536
56. Olness K, Ader R. Conditioning as an adjunct in the pharmacotherapy of lupus erythematosus. J Dev Behav Pediatr 1992; 13: 124-125
57. Klosterhalfen W, Klosterhalfen S. Pavlovian conditioning of immunosuppression modifies adjuvant arthritis in rats. Behav Neurosci 1983; 97: 663-666
58. Klosterhalfen S, Klosterhalfen W. Conditioned immunopharmacologic effects and adjuvant arthritis: Further results. In: Spector NH (ed): Neuroimmunomodulation. Proceedings of the First International Workshop on NIM. Bethesda: IWGN, 1985: 183-187
59. Klosterhalfen S, Klosterhalfen W. Conditioned cyclosporine effects but not conditioned taste aversion in immunized rats. Behav Neurosci 1990; 104: 716-724
60. Giang DW, Goodman AD, Schiffer RB et al. Conditioning of cyclophosphamide-induced leukopenia in humans. J Neuropsychiatry Clin Neurosci 1996; 8: 194-201
61. Gorczynski RM. Conditioned enhancement of skin allografts in mice. Brain Behav Immun 1990; 4: 85-92
62. Grochowicz PM, Schedlowski M, Husband AJ et al. Behavioral conditioning prolongs heart allograft survival in rats. Brain Behav Immun 1991; 5: 349-356
63. Gorczynski RM, Kennedy M, Ciampi A. Cimetidine reverses tumor growth enhancement of plasmacytoma tumors in mice demonstrating conditioned immunosuppression. J Immunol 1985; 134: 4261-4266
64. Chanta VK, Hiramoto RN, Solvason HB, Spector NH. Neural and environmental influences on neoplasia and conditioning of NK activity. J Immunol 1985; 135: 848s-852s
65. Ghanta V, Hiramoto RN, Solvason B, Spector NH. Influence of conditioned natural immunity on tumor growth. Ann N Y Acad Sci 1987; 496: 637-646
66. Ghanta VK, Hiramoto NS, Solvason HB et al. Conditioning: A new approach to immunotherapy. Cancer Res 1990; 50: 4295-4299
67. Newman ME. Can an immune response be conditioned? J Natl Cancer Inst 1990; 82: 1534-1535
68. Hiramoto RN, Hiramoto NS, Rish ME et al. Role of immune cells in the Pavlovian conditioning of specific resistance to cancer. Int J Neurosci 1991; 59: 101-117
69. Stockhorst U, Klosterhalfen S, Klosterhalfen W et al. Anticipatory nausea in cancer patients receiving chemotherapy: Classical conditioning etiology and therapeutical implications. Integr Physiol Behav Sci 1993; 28: 177-181
70. Bernstein IL. Aversion conditioning in response to cancer and cancer treatment. Clin Psychol Rev 1991; 11: 185-191
71. Stockhorst U, Klosterhalfen S, Steingrüber H-J. Conditioned nausea and further side-effects in cancer chemotherapy: A review. Journal of Psychophysiology 1998; 12 (Supplement): 14-33
72. Bovbjerg DH, Redd WH, Maier LA et al. Anticipatory immune suppression and nausea in women receiving cyclic chemotherapy for ovarian cancer. J Consult Clin Psychol 1990; 58: 153-157
73. Fredrikson M, Fürst CJ, Lekander M et al. Trait anxiety and anticipatory immune reactions in women receiving adjuvant chemotherapy for breast cancer. Brain Behav Immun 1993; 7: 79-90
74. Lekander M, Fürst CJ, Rotstein S et al. Does informed adjuvant placebo chemotherapy for breast cancer elicit immune changes? Oncol Rep 1994; 1: 699-703
75. Lekander M, Fürst CJ, Rotstein S et al. Anticipatory immune changes in women treated with chemotherapy for ovarian cancer. Int J Behav Med 1995; 2: 1-12
76. Rosenberg SA. The development of new immunotherapies for the treatment of cancer using interleukin-2. Ann Surg 1988; 208: 121-135
77. Mageed AA, Findley HW, Franco C et al. Natural killer cells in children with acute leukemia. The effect of interleukin-2. Cancer 1987; 60: 2913-2918
78. Valen F Van, Winkelmann W, Burdach S et al. Interferon γ and tumour necrosis factor α induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro. J Cancer Res Clin Oncol 1993; 119: 615-621
79. Bernstein IL. Neural mediation of food aversions and anorexia induced by tumor necrosis factor and tumors. Neurosci Biobehav Rev 1996; 20: 177-181
80. Plata-Salamán CR. Brain mechanisms in cytokine-induced anorexia. Psychoneuroendocrinology 1999; 24: 25-41
81. Stockhorst U. Klassische Konditionierung bei der Gabe von Pharmaka. Lengerich; Pabst Science Publishers, 2003
82. Tracey KJ. The inflammatory reflex. Nature 2002; 420: 853-859
83. Ader R. Conditioned immunomodulation: Research needs and directions. Brain Behav Immun 2003; 17 (S1): S51-S57
84. Steinman L. Elaborate interactions between the immune and nervous systems. Nature Immunol 2004; 5: 575-581
85. Ramírez-Amaya V, Bermúdez-Rattoni F. Conditioned enhancement of antibody production disrupted by insular cortex and amygdala but not hippocampal lesions. Brain Behav Immun 1999; 13: 46-60
86. Ramírez-Amaya V, Alvarez-Borda B, Bermúdez-Rattoni F. Differential effects of NMDA-induced lesions into the insular cortex and amygdala on the acquisition and evocation of conditioned immunosuppression. Brain Behav Immun 1998; 12: 149-160
87. Seligman MEP, Maier SF. Failure to escape traumatic shock. J Exp Psychol 1967; 74: 1-9
88. Laudenslager ML, Ryan SM, Drugan RC et al. Coping and immunosuppression: Inescapable but not escapable shock suppresses lymphocyte proliferation. Science 1983; 221: 568-570
89. Mormede P, Dantzer R, Michaud B et al. Influence of stressor predictability and behavioral control on lymphocyte reactivity, antibody responses and neuroendocrine activation in rats. Physiol Behav 1988; 43: 577-583
90. Sandi C, Borrell J, Guaza C. Behavioral, neuroendocrine, and immunological outcomes of escapable or inescapable shocks. Physiol Behav 1992; 51: 651-656
91. Weisse CS, Pato CN, McAllister CG et al. Differential effects of controllable and uncontrollable acute stress on lymphocyte proliferation and leukocyte percentages in humans. Brain Behav Immun 1990; 4: 339-351
92. Sieber WJ, Rodin J, Larson L et al. Modulation of human natural killer cell activity by exposure to uncontrollable stress. Brain Behav Immun 1992; 6: 141-156
93. Persinger MA, Ossenkopp K-P, Kamaya V, Pear JJ. Physiological changes associated with changing fixed ratio schedules in rats. Psychol Rep 1974; 35: 847-850
94. Sacerdote P, Manfredi B, Bianchi M, Panerai AE. Intermittent but not continuous inescapable footshock stress affects immune responses and immunocyte beta-endorphin concentrations in the rat. Brain Behav Immun 1994; 8: 251-260